Viewing Study NCT02674269

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:53 PM
Ignite Modification Date: 2026-02-25 @ 5:45 PM
Study NCT ID: NCT02674269
Status: WITHDRAWN
Last Update Posted: 2017-06-16
First Post: 2016-02-01
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Safety and Efficacy Study of Intravesical Instillations of BotuGelTM, Slow Release RTGel Based Botox® Formulations, in Idiopathic OAB Patients With Urinary Incontinence ("INTIMO2")
Sponsor: UroGen Pharma Ltd.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Overactive Bladder View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Overactive bladder View
None Botox View
None TC-3 Gel View
None Intravesical View
None UroGen Pharma View
None Botulinum Toxin View
None Urgency View
None OAB View
None Incontinence View
None I-QOL View
None KHQ View
None TBS View
None RTG View